The unfinished measles immunization agenda

被引:43
作者
Strebel, P
Cochi, S
Grabowsky, M
Bilous, J
Hersh, BS
Okwo-Bele, JM
Hoekstra, E
Wright, P
Katz, S
机构
[1] Ctr Dis Control & Prevent, Natl Immunizat Program, Global Immunizat Div, Atlanta, GA 30333 USA
[2] Amer Red Cross, Int Serv, Washington, DC USA
[3] WHO, Expanded Programme Immunizat, CH-1211 Geneva, Switzerland
[4] UN Childrens Fund, New York, NY USA
[5] Vanderbilt Univ, Dept Pediat Infect Dis, Nashville, TN USA
[6] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
关键词
D O I
10.1086/368226
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite achieving and sustaining global measles vaccination coverage of about 80% over the past decade, worldwide measles remains the fifth leading cause of mortality among children aged <5 years. In May 2002, the United Nations Special Session on Children endorsed the goal of reducing measles deaths by half by 2005. Countries and World Health Organization (WHO) regions that adopted aggressive measles control or elimination strategies have shown excellent results. In 2001, countries in the Americas reported an all time low of 537 confirmed measles cases. Substantial progress in measles control has also been achieved in the WHO Western Pacific Region, in seven southern African countries, and in selected countries in WHO European, Eastern Mediterranean, and Southeast Asian regions. The ongoing measles disease burden and availability of safe and effective measles mortality reduction strategies make a compelling case to complete the unfinished agenda of measles immunization.
引用
收藏
页码:S1 / S7
页数:7
相关论文
共 52 条
[1]   VACCINATION AND HERD-IMMUNITY TO INFECTIOUS-DISEASES [J].
ANDERSON, RM ;
MAY, RM .
NATURE, 1985, 318 (6044) :323-329
[2]   Malnutrition and mortality in Kohistan dstrict, Afghanistan, April 2001 [J].
Assefa, F ;
Jabarkhil, MZ ;
Salama, P ;
Spiegel, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (21) :2723-2728
[3]   The challenges and strategies for laboratory diagnosis of measles in an international setting [J].
Bellini, WJ ;
Helfand, RF .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 :S283-S290
[4]   First 5 years of measles elimination in southern Africa: 1996-2000 [J].
Biellik, R ;
Madema, S ;
Taole, A ;
Kutsulukuta, A ;
Allies, E ;
Eggers, R ;
Ngcobo, N ;
Nxumalo, M ;
Shearley, A ;
Mabuzane, E ;
Kufa, E ;
Okwo-Bele, JM .
LANCET, 2002, 359 (9317) :1564-1568
[5]   Measles-rubella mass immunization campaign in Albania, November 2000 [J].
Bino, S ;
Kakarriqi, E ;
Xibinaku, M ;
Ion-Nedelcu, N ;
Bukli, M ;
Emiroglu, N ;
Uzicanin, A .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 :S223-S229
[6]   Progress in the control of measles in Ghana, 1980-2000 [J].
Bosu, WK ;
Essel-Ahun, M ;
Adjei, S ;
Strebel, P .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 :S44-S50
[7]   Future savings from measles eradication in industrialized countries [J].
Carabin, H ;
Edmunds, WJ .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 :S29-S35
[8]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P757
[9]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P120
[10]   Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001) [J].
Cliff, J ;
Simango, A ;
Augusto, O ;
Van der Paal, L ;
Biellik, R .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 :S51-S57